magaldrate 108 MG/ML / simethicone 8 MG/ML Oral Suspension [Ri-Mag Plus]
RxNorm concept 1086970, branded drug (sbd). Prescribable name: Ri-Mag Plus 540 MG / 40 MG in 5 mL Oral Suspension.
- RxCUI
- 1086970
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1086970 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Ri-Mag Plus (magaldrate 108 MG/ML / simethicone 8 MG/ML) Oral Suspension; Ri-Mag Plus 540 MG / 40 MG per 5 ML Oral Suspension
Related concepts
- magaldrate 108 MG/ML (SCDC, consists of)
- simethicone 8 MG/ML (SCDC, consists of)
- magaldrate 108 MG/ML / simethicone 8 MG/ML [Ri-Mag Plus] (SBDC, consists of)
- Oral Suspension (DF, has dose form)
- Ri-Mag Plus (BN, has ingredient)
- magaldrate 108 MG/ML / simethicone 8 MG/ML Oral Suspension (SCD, tradename of)
Linked data
NDCs
- 24385040940
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1086970 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1086970 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1086970. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.